Opus Genetics reported a quarterly loss of $0.14 per share versus the Zacks consensus loss of $0.11, a $0.03 EPS miss. The result compares with a loss of $1.27 per share a year ago (a $1.13 improvement YoY), indicating material year-over-year progress despite the slight miss to estimates.
Opus Genetics reported a quarterly loss of $0.14 per share versus the Zacks consensus loss of $0.11, a $0.03 EPS miss. The result compares with a loss of $1.27 per share a year ago (a $1.13 improvement YoY), indicating material year-over-year progress despite the slight miss to estimates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mixed
Sentiment Score
-0.05
Ticker Sentiment
